Cure Glomerulonephropathy (CureGN) is a consortium dedicated to studying children and adults with minimal change disease (MCD), focal segmental glomerulosclerosis (FSGS), membranous nephropathy (MN) or IgA nephropathy/vasculitis (IgAN/IgAV). CureGN's observational cohort studies of adults and children with glomerular diseases have contributed to stronger understandings of the cause of glomerular diseases, response to therapy, and progression of disease.